These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 26675887

  • 1. The dopamine D1 receptor agonist SKF-82958 effectively increases eye blinking count in common marmosets.
    Kotani M, Kiyoshi A, Murai T, Nakako T, Matsumoto K, Matsumoto A, Ikejiri M, Ogi Y, Ikeda K.
    Behav Brain Res; 2016 Mar 01; 300():25-30. PubMed ID: 26675887
    [Abstract] [Full Text] [Related]

  • 2. Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions.
    Jutkiewicz EM, Bergman J.
    J Pharmacol Exp Ther; 2004 Dec 01; 311(3):1008-15. PubMed ID: 15292458
    [Abstract] [Full Text] [Related]

  • 3. Dopaminergic modulation of risk-based decision making.
    St Onge JR, Floresco SB.
    Neuropsychopharmacology; 2009 Feb 01; 34(3):681-97. PubMed ID: 18668030
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological characterization of the effects of dopamine D(1) agonists on eye blinking in rats.
    Desai RI, Neumeyer JL, Bergman J, Paronis CA.
    Behav Pharmacol; 2007 Dec 01; 18(8):745-54. PubMed ID: 17989512
    [Abstract] [Full Text] [Related]

  • 5. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW, Bergman J.
    J Pharmacol Exp Ther; 1998 Jun 01; 285(3):1163-74. PubMed ID: 9618419
    [Abstract] [Full Text] [Related]

  • 6. Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.
    Gnanalingham KK, Hunter AJ, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1995 Feb 01; 117(4):403-12. PubMed ID: 7604140
    [Abstract] [Full Text] [Related]

  • 7. An in vivo pharmacological evaluation of pardoprunox (SLV308)--a novel combined dopamine D(2)/D(3) receptor partial agonist and 5-HT(1A) receptor agonist with efficacy in experimental models of Parkinson's disease.
    Jones CA, Johnston LC, Jackson MJ, Smith LA, van Scharrenburg G, Rose S, Jenner PG, McCreary AC.
    Eur Neuropsychopharmacol; 2010 Aug 01; 20(8):582-93. PubMed ID: 20434890
    [Abstract] [Full Text] [Related]

  • 8. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats.
    Graham DL, Hoppenot R, Hendryx A, Self DW.
    Psychopharmacology (Berl); 2007 Apr 01; 191(3):719-30. PubMed ID: 16835769
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of 50-kHz ultrasonic vocalizations by dopamine receptor subtype-selective agonists and antagonists in adult rats.
    Scardochio T, Clarke PB.
    Psychopharmacology (Berl); 2013 Apr 01; 226(3):589-600. PubMed ID: 23192317
    [Abstract] [Full Text] [Related]

  • 10. Effects of a dopamine D1 agonist on ketamine-induced spatial working memory dysfunction in common marmosets.
    Nakako T, Murai T, Ikejiri M, Ishiyama T, Taiji M, Ikeda K.
    Behav Brain Res; 2013 Jul 15; 249():109-15. PubMed ID: 23608483
    [Abstract] [Full Text] [Related]

  • 11. Intravitreally-administered dopamine D2-like (and D4), but not D1-like, receptor agonists reduce form-deprivation myopia in tree shrews.
    Ward AH, Siegwart JT, Frost MR, Norton TT.
    Vis Neurosci; 2017 Jan 15; 34():E003. PubMed ID: 28304244
    [Abstract] [Full Text] [Related]

  • 12. Behavioral effects of the R-(+)- and S-(-)-enantiomers of the dopamine D(1)-like partial receptor agonist SKF 83959 in monkeys.
    Desai RI, Neumeyer JL, Paronis CA, Nguyen P, Bergman J.
    Eur J Pharmacol; 2007 Mar 08; 558(1-3):98-106. PubMed ID: 17207791
    [Abstract] [Full Text] [Related]

  • 13. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B, Katz JL, Alling K, Acri JB, Witkin JM.
    J Pharmacol Exp Ther; 1997 Oct 08; 283(1):7-15. PubMed ID: 9336302
    [Abstract] [Full Text] [Related]

  • 14. D1 and D2 dopamine receptors independently regulate spontaneous blink rate in the vervet monkey.
    Elsworth JD, Lawrence MS, Roth RH, Taylor JR, Mailman RB, Nichols DE, Lewis MH, Redmond DE.
    J Pharmacol Exp Ther; 1991 Nov 08; 259(2):595-600. PubMed ID: 1682479
    [Abstract] [Full Text] [Related]

  • 15. D3 dopamine receptors interact with dopamine D1 but not D4 receptors in the GABAergic terminals of the SNr of the rat.
    Cruz-Trujillo R, Avalos-Fuentes A, Rangel-Barajas C, Paz-Bermúdez F, Sierra A, Escartín-Perez E, Aceves J, Erlij D, Florán B.
    Neuropharmacology; 2013 Apr 08; 67():370-8. PubMed ID: 23238327
    [Abstract] [Full Text] [Related]

  • 16. Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.
    Braun AR, Laruelle M, Mouradian MM.
    J Neural Transm (Vienna); 1997 Apr 08; 104(4-5):341-62. PubMed ID: 9295170
    [Abstract] [Full Text] [Related]

  • 17. Dopaminergic control of angiotensin II-induced vasopressin secretion in vitro.
    Rossi NF.
    Am J Physiol; 1998 Oct 08; 275(4):E687-93. PubMed ID: 9755089
    [Abstract] [Full Text] [Related]

  • 18. Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonists.
    Lublin H, Gerlach J, Mørkeberg F.
    Psychopharmacology (Berl); 1994 Apr 08; 114(3):495-504. PubMed ID: 7855208
    [Abstract] [Full Text] [Related]

  • 19. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats.
    Barrett AC, Miller JR, Dohrmann JM, Caine SB.
    Neuropharmacology; 2004 Apr 08; 47 Suppl 1():256-73. PubMed ID: 15464142
    [Abstract] [Full Text] [Related]

  • 20. Evidence for regulation of body temperature in rats by dopamine D2 receptor and possible influence of D1 but not D3 and D4 receptors.
    Chaperon F, Tricklebank MD, Unger L, Neijt HC.
    Neuropharmacology; 2003 Jun 08; 44(8):1047-53. PubMed ID: 12763098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.